Valuation: Southern Acids (M)

Market Cap 420M 103M 89.1M 83.07M 76.31M 144M 9.76B 146M 979M 383M 4.88B 385M 377M 16.17B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -6.08M -1.48M -1.29M -1.2M -1.1M -2.09M -141M -2.11M -14.16M -5.54M -70.54M -5.57M -5.45M -234M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.64%
Yield 2025
1.64%
Yield 2026 1.65%
1 day-1.30%
1 week+0.33%
Current month-1.30%
1 month-2.26%
3 months-3.81%
6 months-12.17%
Current year-4.72%
1 week 3.03
Extreme 3.03
3.08
1 month 3.02
Extreme 3.02
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 15/07/2015
Director of Finance/CFO 58 01/10/2013
Chief Tech/Sci/R&D Officer 38 16/07/2014
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 79 15/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%+0.33%-10.88%-9.55% 103M
-0.25%+0.04%+40.60%+429.12% 6B
-0.89%-0.41%+24.70%+99.18% 1.73B
+0.70%+18.70%+35.54%+91.05% 904M
+0.10%+6.11%+27.07%+7.09% 578M
+3.82%+4.62%+47.83%+112.50% 582M
-0.57%+5.86%-18.25%-31.32% 497M
+0.90%+9.60%+42.58%-3.13% 389M
-0.80%-6.49%-1.12%+0.27% 373M
-0.88%-6.15%-0.44%+24.31% 289M
Average +0.09%+2.55%+18.76%+71.95% 1.14B
Weighted average by Cap. -0.05%+0.57%+32.13%+252.32%

Financials

2025 2026
Net sales 1.11B 270M 234M 219M 201M 380M 25.68B 384M 2.58B 1.01B 12.84B 1.01B 992M 42.53B 934M 228M 198M 184M 169M 321M 21.67B 324M 2.17B 850M 10.83B 856M 837M 35.9B
Net income 36.7M 8.96M 7.78M 7.25M 6.66M 12.6M 852M 12.74M 85.5M 33.43M 426M 33.64M 32.9M 1.41B 37.38M 9.12M 7.92M 7.39M 6.79M 12.83M 868M 12.97M 87.08M 34.04M 434M 34.26M 33.51M 1.44B
Net Debt -367M -89.55M -77.75M -72.5M -66.6M -126M -8.52B -127M -855M -334M -4.26B -336M -329M -14.11B -426M -104M -90.38M -84.27M -77.42M -146M -9.9B -148M -994M -388M -4.95B -391M -382M -16.4B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
05/08/26 MYR 3.030 -1.30% 10,300
31/07/26 MYR 3.070 +1.66% 100
29/07/26 MYR 3.020 -0.33% 3,800
28/07/26 MYR 3.030 -1.30% 6,100
  1. Stock Market
  2. Stocks
  3. 5134 Stock